SCHEMBL2937245

SCHEMBL2937245

O=C1[C@H](Cc2ccccn2)N(Cc2ccnc3ccccc23)C(=O)N1c1ccc(SC(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.51
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937248 1.00 IGF1R (0.51) IGF1RMAPK1KMT2ANTRK1
Trifluoroacetic Acid SCHEMBL3727093 0.95 IGF1R (0.47) IGF1RMAPK1KMT2ANTRK1
SCHEMBL2940631 0.89 IGF1R (0.53) IGF1R
SCHEMBL2940635 0.89 IGF1R (0.53) IGF1R
SCHEMBL2941750 0.86 IGF1R (0.50) IGF1R
SCHEMBL2941751 0.86 IGF1R (0.50) IGF1R
Trifluoroacetic Acid SCHEMBL3736477 0.85 IGF1R (0.49) IGF1R
SCHEMBL2940864 0.85 IGF1R (0.72) IGF1RMAPK1KMT2A
SCHEMBL2940866 0.85 IGF1R (0.72) IGF1RMAPK1KMT2A
SCHEMBL2941625 0.83 IGF1R (0.72) IGF1RNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed